Clinical Course of Hypertrophic Pulmonary Osteoarthropathy in a Patient Receiving Immune Checkpoint Inhibitor Therapy

Clin Lung Cancer. 2020 Jul;21(4):e243-e245. doi: 10.1016/j.cllc.2020.01.004. Epub 2020 Jan 27.

¹ Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH. Electronic address: [email protected].
² Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH.
³ Division of Palliative Medicine, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
⁴ Division of Thoracic Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.
⁵ Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
⁶ Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH.
⁷ Division of Rheumatology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
⁸ Division of Sports Medicine, Department of Family Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.

No abstract available

Keywords: Hydroxychloroquine; Hypertrophic pulmonary osteoarthropathy; Immune checkpoint inhibitors; Lung cancer; Pain.

Publication types